Bristol-Myers Squibb Company Depositary Receipt (BMYB34)
Bovespa
Real-time Data
01:00 PM
Day's Range
343.0852 wk Range
227.85Overview - BMYB34 - Bristol-Myers Squibb Company Depositary Receipt
Key Statistics
Valuation
Enterprise Value
3.80T
P/E (Trailing)
‪14.66‬
PEG Ratio
‪0.09‬
Price / Sales (TTM)
‪14.36‬
Price / Book
‪6.09‬
EV / EBITDA
‪39.13‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪309.44‬
200-Day Avg
‪298.01‬
Dividends
Payout Ratio
‪37.46%‬
Frequency
Quarterly
Peers - BMYB34 - Bristol-Myers Squibb Company Depositary Receipt
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on Bovespa.
- BMYB34BovespaBristol-Myers Squibb Company Depositary Receipt600.98BMarket Cap+9.73%52-week change15.88P/E (Trailing)‪15.00%‬Profit Margin
- ABBV34BovespaAbbVie Inc.2.40TMarket Cap+17.65%52-week change74.19P/E (Trailing)‪9.80%‬Profit Margin
- MRCK34BovespaMerck & Co. Inc.1.64TMarket Cap+29.27%52-week change36.90P/E (Trailing)‪13.58%‬Profit Margin
- N1VS34BovespaNovartis AG1.50TMarket Cap+14.14%52-week change21.88P/E (Trailing)‪23.92%‬Profit Margin
- A1ZN34BovespaAstraZeneca PLC Sponsored BDR1.36TMarket Cap+8.41%52-week change25.52P/E (Trailing)‪17.18%‬Profit Margin
- GILD34BovespaGilead Sciences Inc.825.34BMarket Cap+5.92%52-week change18.11P/E (Trailing)‪30.99%‬Profit Margin
- PFIZ34BovespaPfizer Inc.710.60BMarket Cap-13.79%52-week change18.22P/E (Trailing)‪11.83%‬Profit Margin
Profile Summary - BMYB34 - Bristol-Myers Squibb Company Depositary Receipt
About
Bristol-Myers Squibb Company Depositary Receipt is a form of equity that represents shares in the American pharmaceutical giant Bristol-Myers Squibb. This depositary receipt allows investors outside the United States to own a stake in the company through local exchanges, offering convenience and accessibility to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
